Beta-Adrenergic Antagonists and Cancer Specific Survival in Patients with Advanced Prostate Cancer: A Veterans Administration Cohort Study

Urology ◽  
2021 ◽  
Author(s):  
Natasza M. Posielski ◽  
Kyle A. Richards ◽  
Jinn-ing Liou ◽  
Tudor Borza ◽  
E. Jason Abel ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cohort Study ◽  
Advanced Prostate Cancer ◽  
Veterans Administration ◽  
Cancer Specific Survival ◽  
Beta Adrenergic ◽  
Adrenergic Antagonists

scholarly journals The Role of Genetic Variants in the Association between Dietary Acrylamide and Advanced Prostate Cancer in the Netherlands Cohort Study on Diet and Cancer

2018 ◽  
Vol 70 (4) ◽  
pp. 620-631 ◽  
Author(s):  
Andy Perloy ◽  
Leo J. Schouten ◽  
Piet A. van den Brandt ◽  
Roger Godschalk ◽  
Frederik-Jan van Schooten ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cohort Study ◽  
The Netherlands ◽  
Genetic Variants ◽  
Advanced Prostate Cancer ◽  
Dietary Acrylamide ◽  
Diet And Cancer

849 Nomograms to estimate castration resistance and cancer specific survival in patients with advanced prostate cancer - GESCAP Study

2016 ◽  
Vol 15 (3) ◽  
pp. e849
Author(s):  
F. Gómez-Veiga ◽  
A. Rodriguez-Antolín ◽  
B. Miñana ◽  
J.M. Cozar ◽  
E. Pedrosa
Keyword(s):  
Prostate Cancer ◽  
Advanced Prostate Cancer ◽  
Castration Resistance ◽  
Cancer Specific Survival

Association Between Use of β-Blockers and Prostate Cancer–Specific Survival: A Cohort Study of 3561 Prostate Cancer Patients with High-Risk or Metastatic Disease

2014 ◽  
Vol 65 (3) ◽  
pp. 635-641 ◽  
Author(s):  
Helene Hartvedt Grytli ◽  
Morten Wang Fagerland ◽  
Sophie D. Fosså ◽  
Kristin Austlid Taskén
Keyword(s):  
Prostate Cancer ◽  
Cohort Study ◽  
High Risk ◽  
Cancer Patients ◽  
Metastatic Disease ◽  
Cancer Specific Survival ◽  
Β Blockers

scholarly journals Association between body mass index and obesity-related cancer risk in men and women with type 2 diabetes in primary care in the Netherlands: a cohort study (ZODIAC-56)

BMJ Open ◽  
2018 ◽  
Vol 8 (1) ◽  
pp. e018859 ◽  
Author(s):  
Steven H Hendriks ◽  
Dennis Schrijnders ◽  
Kornelis JJ van Hateren ◽  
Klaas H Groenier ◽  
Sabine Siesling ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Type 2 Diabetes ◽  
Primary Care ◽  
Body Mass Index ◽  
Cohort Study ◽  
Advanced Prostate Cancer ◽  
Men And Women ◽  
Total Group

ObjectiveTo investigate the relationship between body mass index (BMI) and obesity-related cancers in men and women with type 2 diabetes (T2D).DesignObservational cohort study.SettingPrimary care.ParticipantsA total of 52 044 patients with T2D who participated in the ZODIAC (Zwolle Outpatient Diabetes project Integrating Available Care) study between 1998 and 2012 was included (49% women). A dataset of these patients was linked to available information of the Netherlands Cancer Registry to obtain data on cancer incidents.Primary outcome measuresAnalyses were performed for the total group of obesity-related cancers and for non-sex-specific and sex-specific obesity-related cancers (in men: advanced prostate cancer, in women: ovarian, endometrial and postmenopausal breast cancer).ResultsThe median follow-up period in all analyses was 3.1 (1.7–5.0) years in men and 3.1 (1.7–5.1) in women. During follow-up, 689 men and 914 women were diagnosed with an obesity-related cancer. In men, BMI was associated with a higher risk of the total group of obesity-related cancers and non-sex-specific obesity-related cancers (HR (per 5 kg/m2increase) 1.12 (95% CI 1.02 to 1.23) and HR 1.18 (95% CI 1.06 to 1.31)). No association was found with prostate cancer. In women, an association between BMI and all obesity-related cancers combined and sex-specific obesity-related cancers was present (HR 1.15 (95% CI 1.08 to 1.22) and HR 1.22 (95% CI 1.14 to 1.32)). No association with non-sex-specific cancers was found in women.ConclusionsBMI is associated with obesity-related cancers in men with T2D, except with advanced prostate cancer. The results of this study provide reason to reconsider the classification of advanced prostate cancer as an obesity-related cancer, at least in T2D. In women, BMI is associated with the total group of obesity-related cancers and with sex-specific obesity-related cancers.

Sign in / Sign up

Export Citation Format

Share Document